| Gene |
[NEUROG2](/genes/ngn2) |
| UniProt |
Q9H932 |
| PDB |
2VPE, 4JDD |
| Mol. Weight |
34.7 kDa |
| Localization |
Nucleus |
| Family |
bHLH transcription factor family |
| Diseases |
[Alzheimer's Disease](/diseases/alzheimers), Neurodevelopmental Disorders, Epilepsy |
is a protein that ngn2 plays essential roles in:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
NGN2 (Neurogenin-2) is a basic helix-loop-helix (bHLH) transcription factor belonging to the proneural protein family. The protein contains:
- Basic region: DNA-binding domain recognizing the E-box consensus sequence (CANNTG)
- HLH domain: Mediates dimerization with other bHLH proteins such as E2A (TCF3) or HEB (TCF12)
- Transactivation domain: Located at the N-terminus for transcriptional activation
NGN2 functions as a transcriptional activator and is part of the neurogenin family (NGN1, NGN2, NGN3) involved in neuronal determination and differentiation.
NGN2 plays essential roles in:
- Neuronal Determination: Acts as a master regulator of neuronal fate determination
- Cortical Development: Critical for cortical neuron specification and layer formation
- Dopaminergic Neuron Differentiation: Promotes dopaminergic neuron differentiation from neural progenitors
- Excitatory/Inhibitory Balance: Regulates the balance between glutamatergic and GABAergic neuronal fates
- Synapse Formation: Controls genes involved in synaptic development and function
NGN2 activates downstream target genes including neuroD1, Hes6, and various synaptic proteins.
NGN2 is implicated in several neurodegenerative processes:
- NGN2 expression is altered in AD brains
- Promotes neuronal differentiation from neural stem cells
- May help replace degenerated neurons
- Enhances synaptic protein expression
- Used in neuronal reprogramming approaches
- NGN2 dysfunction may contribute to epileptogenesis
- Regulates inhibitory neuron development
- Imbalance in excitatory/inhibitory neurons can lead to hyperexcitability
- NGN2 is a key factor in direct neuronal reprogramming
- Overexpression converts astrocytes into excitatory neurons
- NGN2+ neural progenitors show promise for cell therapy
- Combined with NEUROD1 for robust neuronal conversion
- Mutations in NGN2 cause neurodevelopmental disorders
- Associated with intellectual disability and cortical malformations
NGN2 is being explored as a therapeutic target:
- Direct Neuronal Reprogramming: NGN2-mediated conversion of astrocytes or NG2 glia into neurons
- Cell Replacement: NGN2+ neural progenitors for transplantation
- Gene Therapy: AAV-mediated NGN2 expression to promote neurogenesis
- Combination Approaches: NGN2 with other factors (NEUROD1, ASCL1) for optimal neuronal conversion
- Bertrand et al. (2002). Proneural genes in the development of the mammalian central nervous system. Nature Reviews Neuroscience
- Berninger et al. (2007). Functional properties of neurons derived from in vitro reprogrammed postnatal astrocytes. Neurochemical Research
- Masserdotti et al. (2015). Transcriptional Mechanisms of Neuronal Differentiation. Cold Spring Harbor Perspectives in Biology